SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT
                         PURSUANT TO SECTION 13 OR 15(d)
                     of the Securities Exchange Act of 1934

       Date of report (Date of earliest event reported): November 28, 2000

                               INSMED INCORPORATED
             (Exact name of registrant as specified in its charter)



        VIRGINIA                        0-30739                54-1972729
- ---------------------------------    ------------              ----------
(State or other jurisdiction of    (Commission File Number)  (I.R.S. Employer
     incorporation)                                         Identification No.)



                   800 East Leigh Street, Richmond, VA 23219
             (Address of principal executive offices and zip code)

       Registrant's telephone number, including area code: (804) 828-6893


Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

     (c)  Exhibit.

          99.1    Presentation of November 28, 2000.

Item 9.  Regulation FD Disclosure.

          On November 28, 2000, Insmed Incorporated (the "Company") held a
public conference call with investors.  During the call, Dr. Geoffrey Allan,
Chairman of the Board, President and Chief Executive Officer of the Company,
indicated that the slides relating to his prepared remarks would be furnished
for review on the SEC's website.   The presentation, which is incorporated
herein by reference, is attached hereto as Exhibit 99.1.

     The information in this report (including the exhibit) is furnished
pursuant to Item 9 and shall not be deemed to be "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that Section.  This report will not be deemed an
admission as to the materiality of any information in the report that is
required to be disclosed solely by Regulation FD.


                                       2


                                   SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                             INSMED INCORPORATED


Date: November 30, 2000                      By:  /s/ Michael D. Baer
                                                  __________________________
                                                  Michael D. Baer
                                                  Chief Financial Officer


                                       3


                              INSMED INCORPORATED
                               INDEX TO EXHIBITS

Exhibit Number

99.1  Presentation of November 28, 2000.


                                       4